SCHEMBL6794700

SCHEMBL6794700

Cc1cc([N+](=O)[O-])cnc1NCCc1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
PKM P14618 3/20 0.54
LMNA P02545 3/20 0.51
HTT P42858 2/20 0.51
MAPT P10636 2/20 0.51
GAA P10253 1/20 0.51
POLB P06746 1/20 0.50
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 2/20 0.45
HRH3 Q9Y5N1 1/20 0.43
PGK1 P00558 1/20 0.43
NPC1 O15118 2/20 0.43
TAAR1 Q96RJ0 1/20 0.43
ALOX15 P16050 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
F2 P00734 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6754375 0.88 ALDH1A1 (0.53) ALDH1A1LMNAHTTMAPTGAA
SCHEMBL6793817 0.86 PKM (0.60) ALDH1A1PKMLMNAMAPTGAA
SCHEMBL4844382 0.84 ALDH1A1 (0.70) ALDH1A1PKMLMNAMAPTPOLB
SCHEMBL6798950 0.79 RAB9A (0.50) ALDH1A1LMNAHTTRAB9ASMN1; SMN2
SCHEMBL6496190 0.78 CYP1A2 (0.60) ALDH1A1PKMLMNAMAPTGAA
SCHEMBL3363777 0.77 ALDH1A1 (0.50) ALDH1A1PKMLMNAHTTMAPT
SCHEMBL6787246 0.76 PKM (0.57) ALDH1A1PKMLMNAHTTMAPT
SCHEMBL4820842 0.76 MEN1 (0.65) ALDH1A1LMNAHTTMAPTGAA
SCHEMBL4843988 0.76 ALDH1A1 (0.61) ALDH1A1PKMLMNAHTTMAPT
SCHEMBL6793640 0.75 ALDH1A1 (0.70) ALDH1A1PKMLMNAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed
CN-1478077-A Benzamide compounds as APO B secretion inhibitors ����ҩƷ��ҵ��ʽ���� 2004-02-25 CN disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 ALDH1A1 1427/4885PKM 3447/4885LMNA 1239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.